Stockholm3 - A new option to detect Prostate Cancer

Authors

  • Moosa Zulfiqar Ali Medical College, Combined Military Hospital, Lahore, Pakistan
  • Roshaan Ahmad Medical College, Combined Military Hospital, Lahore, Pakistan
  • Amna Akmal Medical College, Combined Military Hospital, Lahore, Pakistan

DOI:

https://doi.org/10.47391/JPMA.5109

Abstract

Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-treatment, and higher expenses.2 The Karolinska Institutet in Stockholm, Sweden, developed the Stockholm3 test to overcome PSA test’s shortcomings.

---Continue

Downloads

Published

2022-04-05

How to Cite

Ali, M. Z. ., Ahmad, R., & Akmal, A. (2022). Stockholm3 - A new option to detect Prostate Cancer. Journal of the Pakistan Medical Association, 72(4), 784–784. https://doi.org/10.47391/JPMA.5109

Issue

Vol. 72 No. 4 (2022): APRIL

Section

LETTER TO THE EDITOR